Table 1 Baseline demographics
Cohort 1 | Cohort 2 | Overall | |
|---|---|---|---|
(n = 9) | (n = 10) | (n = 19) | |
Mean age, years (range) | 50.0 (36 to 71) | 50.7 (38 to 67) | 50.4 (36 to 71) |
ECOG status, n | |||
0/1/2 | 8/1/0 | 5/5/0 | 13/6/0 |
Previous chemotherapy regimens, n (%) | |||
Any adjuvant regimen | 5 (56) | 9 (90) | 14 (74) |
Taxanea | 7 (78) | 8 (80) | 15 (79) |
First-line setting | 2 (22) | 0 | 2 (11) |
Adjuvant setting | 2 (22) | 6 (60) | 8 (42) |
Neo-adjuvant setting | 3 (33) | 1 (10) | 4 (21) |
Metastatic setting | 0 | 2 (20) | 2 (11) |
Anthracycline | 6 (67) | 6 (60) | 12 (63) |
Capecitabine | 1 (11) | 0 | 1 (5) |